v3.26.3
Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Revenues:        
Net patient revenues $ 397,446,000 $ 370,989,000 $ 1,145,610,000 $ 1,095,945,000
Other revenues 10,525,000 11,672,000 52,207,000 35,323,000
Net operating revenues 407,971,000 382,661,000 1,197,817,000 1,131,268,000
Costs and expenses:        
Salaries, wages, and benefits 251,937,000 233,176,000 728,913,000 687,840,000
Other operating 99,461,000 96,604,000 285,173,000 281,004,000
Facility rent 1,365,000 11,345,000 24,548,000 34,038,000
Depreciation and amortization 14,576,000 11,158,000 37,363,000 33,151,000
Total costs and expenses 367,339,000 352,283,000 1,075,997,000 1,036,033,000
Income from operations 40,632,000 30,378,000 121,820,000 95,235,000
Other income (expense):        
Non–operating income 3,637,000 4,660,000 11,566,000 13,871,000
Interest expense (6,991,000) (1,456,000) (7,273,000) (5,555,000)
Unrealized gains/(losses) on marketable equity securities (17,599,000) 20,827,000 (7,610,000) 26,748,000
Income before income taxes 19,679,000 54,409,000 118,503,000 130,299,000
Income tax provision (5,498,000) (13,400,000) (27,682,000) (32,887,000)
Net income 14,181,000 41,009,000 90,821,000 97,412,000
Net income attributable to noncontrolling interest (544,000) (1,770,000) (1,008,000) (2,246,000)
Net income attributable to National HealthCare Corporation $ 13,637,000 $ 39,239,000 $ 89,813,000 $ 95,166,000
Earnings per share attributable to National HealthCare Corporation stockholders:        
Basic (in dollars per share) $ 0.87 $ 2.53 $ 5.76 $ 6.15
Diluted (in dollars per share) $ 0.85 $ 2.5 $ 5.66 $ 6.1
Basic (in shares) 15,638,814 15,484,464 15,599,724 15,461,804
Diluted (in shares) 15,964,895 15,664,530 15,866,957 15,613,505